Drug intelligence / Profile preview

prostaglandin b2

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

Prostaglandin B2 (PGB2) is a naturally occurring prostanoid, part of the broader eicosanoid family derived from C-20 polyunsaturated fatty acids such as arachidonic acid. It is classified as a small molecule and is considered an experimental compound rather than an approved pharmaceutical drug[1][4]. PGB2 is formed non-enzymatically as a dehydration product of PGE2 or PGA2 under strong basic conditions[9]. It has weak agonist activity at thromboxane-prostanoid (TP) receptors and can increase pulmonary blood pressure in animal models at high doses[9]. Prostaglandins, including PGB2, act locally via G protein-coupled receptors to mediate diverse physiological processes such as inflammation, vascular tone regulation, immune cell modulation, and smooth muscle contraction[4][5][6]. However, unlike other clinically used prostaglandins (e.g., PGE1 analogues), there are no approved therapeutic indications for Prostaglandin B2.

Other names
pgb2pgb-2pgb 2
02

Targets

TYMP (Thymidine phosphorylase)

Beyond the preview

Go deeper on prostaglandin b2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prostaglandin b2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call